期刊文献+

磺胺嘧啶麻黄碱滴鼻液定性定量方法研究 被引量:1

Qualitative and quantitative method of sulfadiazine and ephedrine hydrochloride nasal drops
下载PDF
导出
摘要 目的研究磺胺嘧啶麻黄碱滴鼻液的定性定量方法。方法采用化学反应法及HPLC法定性定量鉴别处方中的磺胺嘧啶及盐酸麻黄碱。采用HPLC法测定磺胺嘧啶及盐酸麻黄碱的含量,色谱柱为Hibar RP-18endcapped(150 mm×4.6 mm,5μm),流动相为磷酸盐缓冲液(pH值为3.0±0.1)-乙腈(90∶10),流速1.0mL·min-1,检测波长210 nm。结果化学反应和HPLC法均能定性鉴别磺胺嘧啶及盐酸麻黄碱。磺胺嘧啶和盐酸麻黄碱分离良好;进样浓度分别为99.96-299.88μg·m L^-1(r=0.999 8,n=5)和19.86-59.58μg·m L^-1(r=0.999 9,n=5)与峰面积呈良好的线性关系。磺胺嘧啶和盐酸麻黄碱的平均回收率在98.0%-100%,RSD均〈1.2%(n=3)。结论本方法简便、快速、准确,重复性好,可用于磺胺嘧啶麻黄碱滴鼻液的质量控制。 Objective To establish a qualitative and quantitative method of sulfadiazine and ephedrine hydrochloride nasal drops. Methods Chemical reaction and HPLC methods were used to identify sulfadiazine and ephedrine hydrochloride. HPLC method was established to determine sulfadiazine and ephedrine hydrochloride. The Hibar RP-18 endcapped(150 mm×4.6 mm, 5 μm) column was used. The flow rate was 1.0 mL·min^- 1 and the detective wavelength was 210 nm. Results Sulfadiazine and ephedrine hydrochloride were identified by chemical reaction and HPLC method. Sulfadiazine and ephedrine hydrochloride were well separated. The calibration curve of sulfadiazine and ephedrine hydrochloride were showed a good linearity at 99.96- 299.88 μg·mL^- 1(r =0.999 8, n=5) and 19.86-59.58 μg·mL^- 1(r = 0.999 9,n = 5). The average recoveries were at 98.0%- 100.0% with RSD 1.2%(n = 3). Conclusion This method is rapid, convenient and accurate, which can be used for the quality control of sulfadiazine and ephedrine hydrochloride nasal drops.
出处 《中南药学》 CAS 2014年第11期1118-1121,共4页 Central South Pharmacy
基金 军队医疗机构制剂标准提高科研专项重点课题(编号:13ZJZ07)
关键词 磺胺嘧啶麻黄碱滴鼻液 磺胺嘧啶 盐酸麻黄碱 鉴别 含量测定 高效液相色谱法 sulfadiazine and ephedrine hydrochloride nasal drop sulfadiazine ephedrine hydrochloride identification content determination HPLC
  • 相关文献

参考文献6

二级参考文献23

  • 1谢天尧,刘绮文,李凤屏,唐亚军,莫金垣.毛细管电泳-方波安培法分离检测滴鼻液中的麻黄碱[J].分析化学,2004,32(7):943-945. 被引量:4
  • 2黄滔敏,杨蓓,刘振,沙云菲,段更利.HPLC法测定磺胺嘧啶麻黄碱滴鼻液的含量[J].中国临床药学杂志,2005,14(4):257-258. 被引量:5
  • 3[12]金巫焕.医用统计方法[M].上海,上海医科大学出版社,1993:208-211.
  • 4[1]上海市医院制剂手册[M].第3版.上海:上海科学技术出版社,1995,339-340.
  • 5[3]United States Pharmacopeial Convention (2000),24th edn[S].The United States Pharmacopeial Convention.MD,USA,pp642-645.
  • 6[5]United States Pharmacopeial Convention (2000),24th edn[S].The United States Pharmacopeial Convention.MD,USA,1565.
  • 7[6]Abd-EIH,Ahmed N,El-Gizawy M.Chemically bonded cyclodextrin stationary phase for the high-performance liquid chromatographic separation and determination of sulphonamides[J].Analyst,1989,114 (5):571-573.
  • 8[7]Pawelczyk E,Zajac M.Kinetics of drug decomposition SLI Specific acid hydrolysis of sulfathiazole[J].Acta Pol Pharm,1976,33 (4):479-484.
  • 9[10]United States Pharmacopeial Convention (2005) Validation of compendial methods in US pharmacopoeia,27th edn[S].The United States Pharmacopeial Convention.MD,USA,2748-2749.
  • 10[11]Hartmann C,Massart DL,McDowall RD.An analysis of the Washington Conference Report on bioanalytical method validation[J].J Pharm Biomed Anal,1994,12 (11):1337-1343.

共引文献96

同被引文献8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部